0GZK Stock Overview
Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 0GZK from our risk checks.
Ion Beam Applications SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €13.40 |
| 52 Week High | €17.11 |
| 52 Week Low | €8.27 |
| Beta | 0.90 |
| 1 Month Change | 7.89% |
| 3 Month Change | 28.60% |
| 1 Year Change | -18.09% |
| 3 Year Change | -22.87% |
| 5 Year Change | -16.41% |
| Change since IPO | -29.32% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0GZK | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | 2.4% | -0.09% | -0.9% |
| 1Y | -18.1% | -10.7% | -1.8% |
Return vs Industry: 0GZK underperformed the UK Medical Equipment industry which returned -10.7% over the past year.
Return vs Market: 0GZK underperformed the UK Market which returned -1.8% over the past year.
Price Volatility
| 0GZK volatility | |
|---|---|
| 0GZK Average Weekly Movement | 5.9% |
| Medical Equipment Industry Average Movement | 7.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0GZK's share price has been volatile over the past 3 months.
Volatility Over Time: 0GZK's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1986 | 2,000 | Olivier Legrain | www.iba-worldwide.com |
Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems.
Ion Beam Applications SA Fundamentals Summary
| 0GZK fundamental statistics | |
|---|---|
| Market cap | €387.98m |
| Earnings (TTM) | -€9.11m |
| Revenue (TTM) | €428.72m |
0.9x
P/S Ratio-42.6x
P/E RatioIs 0GZK overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0GZK income statement (TTM) | |
|---|---|
| Revenue | €428.72m |
| Cost of Revenue | €0 |
| Gross Profit | €428.72m |
| Other Expenses | €437.83m |
| Earnings | -€9.11m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 23, 2024
| Earnings per share (EPS) | -0.31 |
| Gross Margin | 100.00% |
| Net Profit Margin | -2.12% |
| Debt/Equity Ratio | 47.9% |
How did 0GZK perform over the long term?
See historical performance and comparison